Cytokinetics board of directors
WebApr 8, 2024 · SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced changes to its Board of … WebRobert I. Blum President, Chief Executive Officer & Director: Cytokinetics, Inc., Gamida Cell Ltd. John Tannahill Henderson Independent Director: Cytokinetics, Inc. Nancy J. …
Cytokinetics board of directors
Did you know?
WebFeb 20, 2009 · Dr. Henderson joins the Cytokinetics Board of Directors with over 30 years of experience in the life science industry. Since December 2000, Dr. Henderson has served as a consultant to the pharmaceutical industry as president of Futurepharm LLC. Until his retirement in December 2000, Dr. Henderson was an employee of Pfizer Inc. for over 25 … WebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% compared with the industry’s decline of 4.7%.
WebApr 11, 2024 · To elect the Board of Directors' nominees, Edward M. Kaye, M.D., Wendell Wierenga, Ph.D., and Nancy J. Wysenski, as Class I Directors, each to serve for a three-year term and until their successors are duly elected and qualified; WebMar 8, 2012 · Cytokinetics, Incorporated (NASDAQ: CYTK) announced today the resignation of James A. Spudich, Ph.D. from the company's Board of Directors.Dr. Spudich co-founded the company and has served on the company's Board since its inception. Contemporaneously with Dr. Spudich's resignation, the Board has elected Sandford D. …
WebJul 1, 2024 · The grant was previously approved by the Compensation and Talent Committee of Cytokinetics’ Board of Directors under the company’s Amended and Restated 2004 Equity. SOUTH SAN FRANCISCO, Calif ... WebRobert was appointed President and Chief Executive Officer of Cytokinetics in January 2007 and has been a member of our Board of Directors since then. Previously, he served as Cytokinetics’ President and held other senior-level positions at the Company overseeing research and development, finance, corporate development, legal, commercial …
WebApr 7, 2024 · SOUTH SAN FRANCISCO, CA, Mar 07, 2012 (MARKETWIRE via COMTEX) --Cytokinetics, Incorporated (NASDAQ: CYTK) announced today the resignation of …
WebApr 8, 2024 · SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced changes to its Board of Directors. … gold rush white water season 5 episode 8WebFeb 18, 2024 · Appointment Adds to Board Expertise in Commercial Development and Market Access as Company Prepares for Further Corporate Development. SOUTH SAN FRANCISCO, Calif., Feb. 18, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Muna Bhanji has been appointed to the … gold rush white water payWebMar 7, 2015 · Senior Medical Director, Medical Affairs, Cardiovascular Cytokinetics, Inc. Heart Failure focus Learn more about Robb Kociol's work experience, education, connections & more by visiting their ... gold rush: white water season 6 2022Web“Incumbent Directors” means directors who either (A) are Directors as of the effective date of the Plan, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination (but will not include an individual whose election or ... head of the executive in indiaWebFeb 11, 2011 · On behalf of Cytokinetics' management and our Board, we are grateful for his strategic insights and professional oversight that have contributed to the company's … gold rush white water season 5 free onlineWebApr 17, 2024 · Cytokinetics Names Muna Bhanji to Board of Directors. SOUTH SAN FRANCISCO, Calif., Feb. 18, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Muna Bhanji has been appointed to the company’s Board of Directors. Ms. Bhanji brings more than 30 years of strategic and … gold rush: white water season 6 episode 7WebMay 22, 2014 · The audit committee of the Board of Directors has selected PricewaterhouseCoopers independent auditors to audit Cytokinetics financial statements for the fiscal year ending December 31, 2014. gold rush: white water season 6 2023